Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

TELMISARTAN AND AMLODIPINE

AMLODIPINE BESYLATE; TELMISARTAN

Standard Dose
EQ 5MG BASE;40MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview TELMISARTAN AND AMLODIPINE is listed in Drugs@FDA under application 205234 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient AMLODIPINE BESYLATE; TELMISARTAN Form and strength TABLET;ORAL - EQ 5MG BASE;40MG Sponsor ALEMBIC Submission history Latest submission status date: 2016-11-17 00:00:00.

Structured Monograph

Clinical summary

Approval overview TELMISARTAN AND AMLODIPINE is listed in Drugs@FDA under application 205234 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient AMLODIPINE BESYLATE; TELMISARTAN Form and strength TABLET;ORAL - EQ 5MG BASE;40MG Sponsor ALEMBIC Submission history Latest submission status date: 2016-11-17 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.